Literature DB >> 11359316

Vaginal birth after caesarean (VBAC).

B L Flamm1.   

Abstract

This review of vaginal birth after caesarean (VBAC) focuses on practical issues that will be useful for the physician in training and the obstetrician in clinical practice. Although VBAC has long been a common practice in many European nations, the same has not been true in North America. As recently as 1970 essentially all hospitals in the United States maintained a policy that women with a history of previous caesarean delivery would undergo repeat caesarean operations for any and all subsequent births. Although VBAC rates in many nations increased dramatically in the 1980s and 1990s, many aspects of trial of labour (also known as trial of scar) remain controversial at the dawn of the 21st century. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359316     DOI: 10.1053/beog.2000.0150

Source DB:  PubMed          Journal:  Best Pract Res Clin Obstet Gynaecol        ISSN: 1521-6934            Impact factor:   5.237


  4 in total

Review 1.  Delivery after previous cesarean: short-term perinatal outcomes.

Authors:  Ravi M Patel; Lucky Jain
Journal:  Semin Perinatol       Date:  2010-08       Impact factor: 3.300

2.  Factors predisposing to perinatal death related to uterine rupture during attempted vaginal birth after caesarean section: retrospective cohort study.

Authors:  Gordon C S Smith; Jill P Pell; Dharmintra Pasupathy; Richard Dobbie
Journal:  BMJ       Date:  2004-07-19

3.  Socioeconomic position early in adolescence and mode of delivery later in life: findings from a Portuguese birth cohort.

Authors:  Cristina Teixeira; Susana Silva; Milton Severo; Henrique Barros
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

4.  Robson 10-groups classification system to access C-section in two public hospitals of the Federal District/Brazil.

Authors:  Cláudia Vicari Bolognani; Lílian Barros de Sousa Moreira Reis; Adriano Dias; Iracema de Mattos Paranhos Calderon
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.